PARP and PARG inhibitors in cancer treatment

D Slade - Genes & development, 2020 - genesdev.cshlp.org
Oxidative and replication stress underlie genomic instability of cancer cells. Amplifying
genomic instability through radiotherapy and chemotherapy has been a powerful but …

State-of-the-art strategies for targeting the DNA damage response in cancer

PG Pilié, C Tang, GB Mills, TA Yap - Nature reviews Clinical oncology, 2019 - nature.com
Genomic instability is a key hallmark of cancer that arises owing to defects in the DNA
damage response (DDR) and/or increased replication stress. These alterations promote the …

Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer

G Petroni, LC Cantley, L Santambrogio… - Nature Reviews …, 2022 - nature.com
A variety of targeted anticancer agents have been successfully introduced into clinical
practice, largely reflecting their ability to inhibit specific molecular alterations that are …

Fucoidan structure and activity in relation to anti-cancer mechanisms

G Van Weelden, M Bobiński, K Okła, WJ Van Weelden… - Marine drugs, 2019 - mdpi.com
Fucoidan is a natural derived compound found in different species of brown algae and in
some animals, that has gained attention for its anticancer properties. However, the exact …

Molecular genetics of endometrial carcinoma

DW Bell, LH Ellenson - Annual Review of Pathology …, 2019 - annualreviews.org
Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United
States. Endometrioid endometrial carcinomas constitute approximately 85% of newly …

Targeted therapies in gynecological cancers: A comprehensive review of clinical evidence

Q Wang, H Peng, X Qi, M Wu, X Zhao - Signal transduction and …, 2020 - nature.com
Advanced and recurrent gynecological cancers are associated with poor prognosis and lack
of effective treatment. The developments of the molecular mechanisms on cancer …

Homologous recombination repair gene mutations to predict olaparib plus bevacizumab efficacy in the first-line ovarian cancer PAOLA-1/ENGOT-ov25 trial

E Pujade-Lauraine, J Brown, A Barnicle… - JCO Precision …, 2023 - ascopubs.org
PURPOSE The PAOLA-1/ENGOT-ov25 trial of maintenance olaparib plus bevacizumab for
newly diagnosed advanced high-grade ovarian cancer demonstrated a significant …

Endometrial cancer: Molecular markers and management of advanced stage disease

RC Arend, BA Jones, A Martinez, P Goodfellow - Gynecologic oncology, 2018 - Elsevier
Endometrial cancer is the most prevalent gynecologic cancer in the United States. Over the
last 10 years, death rates from endometrial cancer have been rising about 1.4% per year …

Research progress on the PI3K/AKT signaling pathway in gynecological cancer

X Shi, J Wang, Y Lei, C Cong… - Molecular medicine …, 2019 - spandidos-publications.com
Abstract The phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (AKT) signaling pathway
is involved in the regulation of multiple cellular physiological processes by activating …

[HTML][HTML] Targeting DNA double-strand break repair pathways to improve radiotherapy response

M Toulany - Genes, 2019 - mdpi.com
More than half of cancer patients receive radiotherapy as a part of their cancer treatment.
DNA double-strand breaks (DSBs) are considered as the most lethal form of DNA damage …